This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n8http://linked.opendata.cz/resource/domain/vavai/subjekt/
n7http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n10http://bibframe.org/vocab/
n17http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00023001%3A_____%2F12%3A00056404%21RIV13-MZ0-00023001/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n16http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00023001%3A_____%2F12%3A00056404%21RIV13-MZ0-00023001
rdf:type
skos:Concept n7:Vysledek
rdfs:seeAlso
http://ac.els-cdn.com/S1590865811003033/1-s2.0-S1590865811003033-main.pdf?_tid=73b0dbb97f4221aee239e2473fe59b67&acdnat=1333453187_7557f4136dc503a311e0a3c1bd6a3366
dcterms:description
Background: Duodenal stenting has become a broadly accepted first line of treatment for patients with advanced malignant gastroduodenal obstruction as these patients are difficult to treat and are poor surgical candidates. Aims: To document duodenal stent performance for palliative management of malignant gastroduodenal obstruction. Methods: Multicentre, single arm, prospective registry documenting peroral endoscopic duodenal stenting procedures in 202 patients. Results: Technical success achieved in 98% (CI. 95%, 99%) of stent placements. Increase of Gastric Outlet Obstruction Score by at least 1 point compared to baseline was achieved in 91% (CI, 86%, 95%) of patients persisting for a median of 184 days (CI, 109, 266). By day 5 (CI, 4,6) after stent placement, 50% of patients experienced a score increase of at least 1 point. Improvement from 14% of patients at baseline tolerating soft solids or low residue/normal diet to 84% at 15 days, 86% at 30 days, 81% at 90 days, 79% at 180 days, and 70% at 270 days. Complications included stent ingrowth and/or overgrowth (12.4%), transient periprocedural symptoms (3%), bleeding (3%), stent migration (1.5%), and perforation (0.5%). Conclusions: Safety and effectiveness of duodenal stenting for palliation of malignant gastroduodenal obstruction was confirmed in the largest international prospective series to date. (C) 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved. Background: Duodenal stenting has become a broadly accepted first line of treatment for patients with advanced malignant gastroduodenal obstruction as these patients are difficult to treat and are poor surgical candidates. Aims: To document duodenal stent performance for palliative management of malignant gastroduodenal obstruction. Methods: Multicentre, single arm, prospective registry documenting peroral endoscopic duodenal stenting procedures in 202 patients. Results: Technical success achieved in 98% (CI. 95%, 99%) of stent placements. Increase of Gastric Outlet Obstruction Score by at least 1 point compared to baseline was achieved in 91% (CI, 86%, 95%) of patients persisting for a median of 184 days (CI, 109, 266). By day 5 (CI, 4,6) after stent placement, 50% of patients experienced a score increase of at least 1 point. Improvement from 14% of patients at baseline tolerating soft solids or low residue/normal diet to 84% at 15 days, 86% at 30 days, 81% at 90 days, 79% at 180 days, and 70% at 270 days. Complications included stent ingrowth and/or overgrowth (12.4%), transient periprocedural symptoms (3%), bleeding (3%), stent migration (1.5%), and perforation (0.5%). Conclusions: Safety and effectiveness of duodenal stenting for palliation of malignant gastroduodenal obstruction was confirmed in the largest international prospective series to date. (C) 2011 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
dcterms:title
Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: An international prospective multicentre registry Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: An international prospective multicentre registry
skos:prefLabel
Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: An international prospective multicentre registry Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: An international prospective multicentre registry
skos:notation
RIV/00023001:_____/12:00056404!RIV13-MZ0-00023001
n7:predkladatel
n8:ico%3A00023001
n3:aktivita
n13:N
n3:aktivity
N
n3:cisloPeriodika
1
n3:dodaniDat
n16:2013
n3:domaciTvurceVysledku
n15:1493396
n3:druhVysledku
n11:J
n3:duvernostUdaju
n18:S
n3:entitaPredkladatele
n17:predkladatel
n3:idSjednocenehoVysledku
175048
n3:idVysledku
RIV/00023001:_____/12:00056404
n3:jazykVysledku
n12:eng
n3:klicovaSlova
Malignant gastric and duodenal stricture; Gastric Outlet Obstruction Score; Endoscopic stenting; Duodenal stem
n3:klicoveSlovo
n14:Malignant%20gastric%20and%20duodenal%20stricture n14:Duodenal%20stem n14:Endoscopic%20stenting n14:Gastric%20Outlet%20Obstruction%20Score
n3:kodStatuVydavatele
US - Spojené státy americké
n3:kontrolniKodProRIV
[7FC78F38C68B]
n3:nazevZdroje
Digestive and liver disease
n3:obor
n9:FE
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
17
n3:rokUplatneniVysledku
n16:2012
n3:svazekPeriodika
44
n3:tvurceVysledku
Johnsson, Erik Shaw, John Roy, Andre Messmann, Helmut Mutignani, Massimiliano Laugier, Rene Costamagna, Guido Neuhaus, Horst Špičák, Julius De Moura, Eduardo GH Tringali, Andrea Bittinger, Max Igea Ariqueta, Francisco Ponchon, Thierry Saarnio, Juha Cheng, Spencer Schumacher, Brigitte
n3:wos
000301205000007
s:issn
1590-8658
s:numberOfPages
7
n10:doi
10.1016/j.dld.2011.08.012